GO:0008016 regulation of heart contraction: Physiological Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008016 regulation of heart contraction describes any process that modulates the frequency, rate or extent of heart contraction, the volume-decreasing action that propels blood through the body.
• Cardiac contraction is fueled by dynamic intracellular ATP, and its regulation is tightly linked to excitation-contraction coupling in ventricular myocytes.
• Adrenergic signaling, particularly via beta1-adrenergic receptors, is a central regulator of contraction force and frequency, and its dysfunction is implicated in heart failure.
• Thyroid hormones and other systemic factors also modulate heart function, highlighting the multi-layered nature of contraction regulation.
• Evolutionary and developmental studies show that the building plan of the vertebrate heart is conserved, providing context for how contraction regulation evolved.
• Experimental models ranging from cultured heart cells to mathematical simulations are used to dissect the molecular and cellular mechanisms of contraction regulation.
Description
The regulation of heart contraction (GO:0008016) is a fundamental biological process that ensures the heart pumps blood efficiently to meet the body's metabolic demands. This process encompasses any mechanism that modulates the frequency, rate, or extent of cardiac contraction, from ion channel activity to neurohumoral signaling. Understanding how contraction is regulated is critical for researchers studying cardiovascular physiology, heart failure, and therapeutic interventions. The heart's ability to adjust its output on a beat-to-beat basis relies on dynamic regulation of intracellular ATP and calcium handling, as demonstrated in ventricular myocytes. Moreover, mathematical models of beta1-adrenergic regulation have provided quantitative insights into how signaling cascades translate into changes in contraction. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0008016, covering its definition, mechanisms, key genes, disease relevance, and experimental approaches.
regulation of heart contraction At A Glance
| GO ID | GO:0008016 |
|---|---|
| GO term | regulation of heart contraction |
| Ontology | biological_process |
| Synonym | regulation of cardiac contraction |
| Definition | Any process that modulates the frequency, rate or extent of heart contraction. Heart contraction is the process in which the heart decreases in volume in a characteristic way to propel blood through the body. |
| Major function | Modulation of the force, rate, and rhythm of cardiac muscle contraction to maintain adequate blood circulation. |
| Related processes | Excitation-contraction coupling, adrenergic signaling, thyroid hormone signaling, force-frequency relationship. |
| Key cellular components | Sarcomere, ion channels, beta-adrenergic receptors, ATP-sensitive potassium channels. |
| Research relevance | Target for heart failure, arrhythmia, and metabolic heart disease therapies. |
What Is GO:0008016?
According to the Gene Ontology, GO:0008016 regulation of heart contraction is defined as any process that modulates the frequency, rate or extent of heart contraction. Heart contraction itself is the process in which the heart decreases in volume in a characteristic way to propel blood through the body. This regulation can occur at multiple levels, including the modulation of cardiac muscle cell excitability, calcium handling, and force generation, as well as systemic influences such as autonomic nervous system activity and hormonal signals.
Why Is regulation of heart contraction Important in Cell Biology?
Regulation of heart contraction is essential for survival because it allows the heart to adapt its output to changing physiological demands, such as during exercise, stress, or rest. Dysregulation of this process is a hallmark of numerous cardiovascular diseases, including heart failure, where beta-adrenergic receptor signaling is often impaired. Moreover, understanding the molecular underpinnings of contraction regulation can inform the development of pharmacological and genetic therapies aimed at restoring normal cardiac function.
• Maintains cardiac output and blood pressure homeostasis.
• Enables rapid adaptation to exercise and stress via adrenergic signaling.
• Dysregulation contributes to heart failure and arrhythmias.
• Thyroid hormones modulate heart function, linking endocrine disorders to cardiac performance.
• Provides targets for pharmacological intervention, such as beta-blockers.
• Informs tissue engineering and regenerative medicine approaches for heart repair.
• Mathematical models help predict drug effects on contraction.
• Evolutionary conservation of heart building plans aids comparative studies.
• Cultured heart cells serve as models for studying contraction regulation.
• Dynamic ATP regulation is critical for sustaining contraction.
What Happens During regulation of heart contraction?
Excitation-Contraction Coupling and ATP Dynamics
In simple terms: When a heart cell is stimulated, it uses energy to contract and pump blood.
Excitation-contraction coupling is the process that links electrical excitation of the cardiac muscle cell membrane to the mechanical contraction of the sarcomere. This process is highly energy-dependent, and recent studies have shown that intracellular ATP levels are dynamically regulated during contraction in ventricular myocytes, ensuring that the heart has sufficient energy for each beat. The regulation of heart contraction therefore involves tight coordination between energy supply and demand.
Adrenergic Regulation of Contraction
In simple terms: Stress hormones make the heart beat harder and faster.
Beta1-adrenergic receptors play a central role in regulating heart contraction. Upon activation by catecholamines, these receptors initiate signaling cascades that enhance calcium handling and myofilament sensitivity, leading to increased force and rate of contraction. Mathematical models have been developed to quantify these effects in mouse ventricular myocytes, providing insights into how beta1-adrenergic regulation modulates contraction dynamics. The force-frequency effect, where increasing heart rate enhances contractility, is also under adrenergic control.
Hormonal and Systemic Modulation
In simple terms: Hormones like thyroid hormone can change how strongly the heart contracts.
Thyroid hormones are important regulators of heart function, influencing heart rate, contractility, and cardiac output. Alterations in thyroid hormone levels can lead to cardiac dysfunction, and the mechanisms involve both genomic and non-genomic effects on cardiac myocytes. Additionally, other systemic factors such as colchicine have been shown to stimulate the rate of contraction in cultured heart cells, indicating that contraction regulation can be influenced by diverse stimuli.
Evolutionary and Developmental Aspects
In simple terms: The way hearts are built and how they contract has evolved over time.
The building plan of the vertebrate heart has evolved to support efficient contraction and regulation. Comparative studies across species reveal conserved mechanisms in heart development and function, providing a framework for understanding how contraction regulation is integrated into the overall cardiovascular system. This evolutionary perspective helps researchers identify core regulatory pathways that are essential for heart function.
Key Genes Involved in GO:0008016 regulation of heart contraction
The following genes and proteins are key players in the regulation of heart contraction, based on their established roles in cardiac physiology and signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB1 | Beta1-adrenergic receptor; mediates catecholamine-induced increases in heart rate and contractility | Target for beta-blockers in heart failure; studied in knockout and transgenic models |
| ADRB2 | Beta2-adrenergic receptor; modulates cardiac contractility and relaxation | Polymorphisms linked to heart failure outcomes; potential therapeutic target |
| ATP2A2 | SERCA2a calcium pump; regulates calcium reuptake into sarcoplasmic reticulum | Defects linked to heart failure; target for gene therapy |
| RYR2 | Ryanodine receptor 2; mediates calcium release from sarcoplasmic reticulum | Mutations cause arrhythmias; studied in knock-in models |
| TNNT2 | Cardiac troponin T; regulates actin-myosin interaction | Mutations cause hypertrophic cardiomyopathy; used in disease modeling |
| MYH7 | Beta-myosin heavy chain; motor protein for contraction | Mutations linked to cardiomyopathy; target for CRISPR correction |
| ACTC1 | Cardiac actin; structural component of sarcomere | Mutations associated with heart disease; studied in iPSC-derived cardiomyocytes |
| PLN | Phospholamban; inhibits SERCA2a, regulating calcium cycling | Knockout mice show enhanced contractility; target for heart failure therapy |
| CALM1 | Calmodulin; calcium sensor regulating ion channels and signaling | Mutations cause long QT syndrome; studied in functional assays |
| KCNQ1 | Potassium channel; repolarization phase of action potential | Mutations cause long QT syndrome; used in electrophysiology studies |
| SCN5A | Sodium channel; depolarization phase of action potential | Mutations linked to Brugada syndrome; target for drug screening |
| NPPA | Atrial natriuretic peptide; regulates blood pressure and volume | Biomarker for heart failure; studied in overexpression models |
| NPPB | B-type natriuretic peptide; marker of cardiac stress | Diagnostic marker; used in clinical research |
| GATA4 | Transcription factor; regulates cardiac gene expression | Mutations associated with congenital heart disease; studied in KO models |
| MEF2C | Transcription factor; controls cardiac development and hypertrophy | Target for heart regeneration research |
| TBX5 | Transcription factor; essential for heart development | Mutations cause Holt-Oram syndrome; used in developmental studies |
| HCN4 | Hyperpolarization-activated cyclic nucleotide-gated channel; pacemaker current | Regulates heart rate; target for pacemaker research |
| CACNA1C | L-type calcium channel; mediates calcium influx | Mutations cause Timothy syndrome; studied in electrophysiology |
How Is regulation of heart contraction Regulated?
The regulation of heart contraction is itself subject to multiple layers of control. Adrenergic signaling via beta1-adrenergic receptors is a primary mechanism, and its desensitization or downregulation is a hallmark of heart failure. The force-frequency relationship, where contractility increases with heart rate, is modulated by adrenergic stimulation and calcium handling. Thyroid hormones exert both genomic and non-genomic effects on cardiac contractility, and their dysregulation can lead to cardiac dysfunction. Additionally, intracellular ATP dynamics are tightly regulated to match energy supply with demand during contraction. Mathematical models have been developed to integrate these regulatory pathways and predict contractile responses under various conditions.
regulation of heart contraction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADRB1 | Heart failure; altered adrenergic signaling | Knockout mouse, overexpression in cardiomyocytes |
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | Knock-in mouse with patient mutation |
| KCNQ1 | Long QT syndrome | Knockout and point-mutation models in iPSC-derived cardiomyocytes |
| TNNT2 | Hypertrophic cardiomyopathy | Knock-in mouse, CRISPR-corrected iPSCs |
| PLN | Heart failure; enhanced contractility in knockout | Knockout mouse, overexpression models |
Heart Failure
Heart failure is characterized by impaired regulation of heart contraction, often due to desensitization of beta-adrenergic receptors and altered calcium handling. Beta-blocker therapy, which targets these pathways, is a cornerstone of heart failure management. Studies have shown that beta1-adrenergic receptor regulation is critical for maintaining contractile function, and its dysfunction contributes to disease progression.
Arrhythmias and Channelopathies
Mutations in genes encoding ion channels and calcium-handling proteins can disrupt the regulation of heart contraction, leading to arrhythmias. For example, mutations in RYR2 and KCNQ1 alter excitation-contraction coupling and repolarization, causing long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. These conditions highlight the importance of precise regulation of contraction for normal cardiac rhythm.
Thyroid Hormone Disorders
Thyroid dysfunction, such as hyperthyroidism or hypothyroidism, can significantly affect heart contraction regulation. Thyroid hormones modulate cardiac gene expression and ion channel function, and their imbalance can lead to tachycardia, heart failure, or arrhythmias. Understanding these interactions is essential for managing cardiovascular complications in thyroid disease.
From regulation of heart contraction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ADRB1 affect heart rate regulation? | ADRB1 knockout mouse |
| How does a specific RYR2 mutation alter calcium handling? | RYR2 point-mutation knock-in mouse |
| Can overexpression of SERCA2a improve contractility in heart failure? | SERCA2a overexpression in cardiomyocytes |
| What is the role of PLN phosphorylation in beta-adrenergic response? | PLN phospho-mutant knock-in mouse |
| Does thyroid hormone directly modulate myofilament sensitivity? | In vitro motility assay with thyroid hormone treatment |
| How do genetic variants in KCNQ1 affect action potential duration? | KCNQ1 knock-in iPSC-derived cardiomyocytes |
How to Study the regulation of heart contraction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion channel currents and action potentials | Studying ion channel mutations in arrhythmias |
| Calcium imaging | Intracellular calcium transients | Assessing excitation-contraction coupling |
| Traction force microscopy | Contractile force of single cardiomyocytes | Evaluating drug effects on contractility |
| Mathematical modeling | Simulated contractile responses | Predicting beta-adrenergic effects |
| Cell culture contraction assay | Rate and extent of contraction in vitro | Screening for modulators |
| Western blot | Protein expression and phosphorylation | Quantifying signaling pathway activation |
| RNA sequencing | Transcriptomic changes | Identifying gene expression changes in disease models |
Mathematical Modeling
Mathematical models of cardiac myocyte contraction integrate experimental data on ion channels, calcium handling, and adrenergic signaling to predict contractile behavior. These models are particularly useful for understanding complex feedback loops and for simulating drug effects, as demonstrated in studies of beta1-adrenergic regulation.
Cell Culture and Contraction Assays
Cultured heart cells, such as primary cardiomyocytes or iPSC-derived cardiomyocytes, can be used to measure contraction rate and force. For example, colchicine was shown to stimulate the rate of contraction in cultured heart cells, illustrating the utility of these assays for screening modulators.
Genetically Modified Animal Models
Knockout, knock-in, and transgenic mouse models are essential for dissecting the role of specific genes in heart contraction regulation. For instance, beta1-adrenergic receptor knockout mice have been used to study the contribution of this receptor to cardiac function.
Electrophysiology and Calcium Imaging
Patch-clamp electrophysiology and calcium imaging techniques allow direct measurement of ion channel activity and intracellular calcium transients, which are key to understanding excitation-contraction coupling and its regulation.
How CRISPR Can Be Used to Study GO:0008016 regulation of heart contraction
Knockout
CRISPR knockout models are used to completely abolish the expression of genes involved in heart contraction regulation, such as ADRB1 or PLN, to study their loss-of-function effects on cardiac physiology. These models help determine whether a gene is essential for normal contraction and can reveal compensatory mechanisms.
Point Mutation
Point mutations can be introduced via CRISPR to mimic human disease-associated variants in genes like RYR2 or KCNQ1. These models allow researchers to study the precise molecular consequences of specific mutations on contraction regulation and to test targeted therapies.
Knock-in
Knock-in models enable the insertion of reporter tags or human disease alleles into the endogenous locus. For example, knocking in a fluorescent tag into the MYH7 gene allows real-time visualization of myosin dynamics in contracting cardiomyocytes.
Overexpression
CRISPR activation or transgenic overexpression can increase the expression of genes such as SERCA2a or PLN to enhance or suppress contractility. These models are valuable for testing whether upregulating a specific gene can rescue heart failure phenotypes.
How EDITGENE Supports regulation of heart contraction Research
Researchers studying regulation of heart contraction-related genes often need to determine whether a candidate gene is causally involved in cardiac physiology or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation of genes identified through genomic or transcriptomic studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of heart contraction research.
Frequently Asked Questions About regulation of heart contraction
What is GO:0008016 regulation of heart contraction?
GO:0008016 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of heart contraction, which is the volume-decreasing action that propels blood through the body.
What genes are involved in regulation of heart contraction?
Key genes include ADRB1, ADRB2, ATP2A2, RYR2, TNNT2, MYH7, PLN, and KCNQ1, among others, which encode receptors, ion channels, and sarcomeric proteins.
How is heart contraction regulated by beta-adrenergic signaling?
Beta1-adrenergic receptors respond to catecholamines by activating signaling cascades that increase calcium handling and myofilament sensitivity, thereby enhancing contraction force and rate.
What role does ATP play in heart contraction regulation?
Intracellular ATP is dynamically regulated during excitation-contraction coupling to meet the energy demands of contraction, as shown in ventricular myocytes.
How do thyroid hormones affect heart contraction?
Thyroid hormones modulate cardiac gene expression and ion channel function, influencing heart rate and contractility; imbalances can lead to cardiac dysfunction.
What diseases are associated with dysregulation of heart contraction?
Heart failure, arrhythmias, and thyroid hormone disorders are among the diseases linked to impaired regulation of heart contraction.
What model systems are used to study regulation of heart contraction?
Models include cultured heart cells, genetically modified mice, iPSC-derived cardiomyocytes, and mathematical simulations.
How can CRISPR be used to study heart contraction genes?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to dissect gene function in cardiac cells and animals.
What is the force-frequency effect in heart contraction?
The force-frequency effect is the phenomenon where increasing heart rate enhances contractility, and it is modulated by adrenergic signaling.
Why is regulation of heart contraction important for drug development?
Understanding contraction regulation helps identify therapeutic targets for heart failure and arrhythmias, and models can predict drug responses.
Conclusion
The regulation of heart contraction (GO:0008016) is a complex, multi-layered process essential for cardiovascular homeostasis. From dynamic ATP regulation to adrenergic and hormonal modulation, researchers have uncovered critical mechanisms that govern cardiac performance. Dysregulation of these pathways underlies major cardiovascular diseases, making this GO term a focal point for therapeutic development. Advanced experimental models, including CRISPR-engineered cells and animals, continue to illuminate the genetic and molecular basis of contraction regulation, offering hope for novel treatments.
References
- 1. Rhana P et al.. 2024. Fueling the heartbeat: Dynamic regulation of intracellular ATP during excitation-contraction coupling in ventricular myocytes.. Proc Natl Acad Sci U S A 121(25):e2318535121 PMID: 38865270
- 2. Nayler WG et al.. 1974. Regulation of myocardial contraction.. Adv Cardiol 12(0):45-58 PMID: 4365841
- 3. Mullins PD et al.. 2020. Mathematical model for β(1)-adrenergic regulation of the mouse ventricular myocyte contraction.. Am J Physiol Heart Circ Physiol 318(2):H264-H282 PMID: 31834834
- 4. Klein I. 1983. Colchicine stimulates the rate of contraction of heart cells in culture.. Cardiovasc Res 17(8):459-65 PMID: 6616518
- 5. Ruffolo RR Jr et al.. 1986. Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.. Am J Med 80(2B):67-72 PMID: 2868661
- 6. Ross J Jr. 1998. Adrenergic regulation of the force-frequency effect.. Basic Res Cardiol 93 Suppl 1:95-101 PMID: 9833136
- 7. Telkova IL et al.. 2004. [Role of thyroid hormones in regulation of heart function].. Klin Med (Mosk) 82(1):12-8 PMID: 15022589
- 8. Jensen B et al.. 2013. Evolution and development of the building plan of the vertebrate heart.. Biochim Biophys Acta 1833(4):783-94 PMID: 23063530
